Concepedia

Publication | Closed Access

Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase

DOI

95

Citations

24

References

2011

Year

Francis J. Giles, Hagop M. Kantarjian, Philipp D. le Coutre, Michele Baccarani, F.-X. Mahon, Rick E. Blakesley, Neil J. Gallagher, Kris Gillis, Stuart L. Goldberg, Richard A. Larson,
Leukemia

References

YearCitations

Page 1